Our Vision 2025, established in 2020, articulates our five-year key imperatives enabling us to be the leading muscle biology biopharmaceutical company that meaningfully improves the lives of patients with diseases of impaired muscle function through access to novel medicines arising from our research.

This vision guides our strategic direction and decision-making, and provides a consistent framework for achieving our goals as a company and as individuals.